• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

ElectroCore - Articles and news items

ElectroCore’s non-invasive vagus nerve (nVNS) stimulation therapy shown to be safe and to produce no meaningful cardiac adverse effects

Industry news / 28 April 2015 / Victoria White

Open-label trial shows electroCore’s nVNS therapy does not cause any meaningful cardiovascular adverse effects in patients with asthma…


Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringWATCH NOW
+ +